Trial description:
Adjuvant immunotherapy in patients with resected gastric cancer following preoperative chemotherapy with high risk for recurrence (N+ and/or R1): an open label randomized controlled phase-2-study
Contact name:
Dr Lizzie Smyth
Trial start date:
Friday, August 16, 2019
Trial end date:
Saturday, August 1, 2020
Trial tumour type:
Oesophageal
Show on Radiotherapy:
No
